• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型青蒿琥酯-二甲双胍偶联物通过簇集素/固醇调节元件结合蛋白1/脂肪酸合酶信号通路抑制膀胱癌细胞生长。

Novel artesunate-metformin conjugate inhibits bladder cancer cell growth associated with Clusterin/SREBP1/FASN signaling pathway.

作者信息

Lin Peiyu, Yang Xiyue, Wang Linghui, Zou Xin, Mu Lingli, Xu Cangcang, Yang Xiaoping

机构信息

Key Laboratory of Study and Discovery of Small Targeted Molecules of Hunan Province, Department of Pharmacy, School of Medicine, Hunan Normal University, Changsha 410000, Hunan, China.

出版信息

Korean J Physiol Pharmacol. 2024 May 1;28(3):219-227. doi: 10.4196/kjpp.2024.28.3.219.

DOI:10.4196/kjpp.2024.28.3.219
PMID:38682170
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11058549/
Abstract

Bladder cancer remains the 10th most common cancer worldwide. In recent years, metformin has been found to have potential anti-bladder cancer activity while high concentration of IC at millimolar level is needed, which could not be reached by regular oral administration route. Thus, higher efficient agent is urgently demanded for clinically treating bladder cancer. Here, by conjugating artesunate to metformin, a novel artesunate-metformin dimer triazine derivative AM2 was designed and synthesized. The inhibitory effect of AM2 on bladder cancer cell line T24 and the mechanism underlying was determined. Anti-tumor activity of AM2 was assessed by MTT, cloning formation and wound healing assays. Decreasing effect of AM2 on lipogenesis was determined by oil red O staining. The protein expressions of Clusterin, SREBP1 and FASN in T24 cells were evaluated by Western blotting. The results show that AM2 significantly inhibited cell proliferation and migration at micromolar level, much higher than parental metformin. AM2 reduced lipogenesis and down-regulated the expressions of Clusterin, SREBP1 and FASN. These results suggest that AM2 inhibits the growth of bladder cancer cells T24 by inhibiting cellular lipogenesis associated with the Clusterin/SREBP1/FASN signaling pathway.

摘要

膀胱癌仍然是全球第十大常见癌症。近年来,已发现二甲双胍具有潜在的抗膀胱癌活性,然而需要毫摩尔水平的高浓度药物,而常规口服给药途径无法达到这一浓度。因此,临床上迫切需要更高效的药物来治疗膀胱癌。在此,通过将青蒿琥酯与二甲双胍偶联,设计并合成了一种新型青蒿琥酯-二甲双胍二聚体三嗪衍生物AM2。测定了AM2对膀胱癌细胞系T24的抑制作用及其潜在机制。通过MTT、克隆形成和伤口愈合试验评估AM2的抗肿瘤活性。通过油红O染色测定AM2对脂肪生成的降低作用。通过蛋白质免疫印迹法评估T24细胞中Clusterin、SREBP1和FASN的蛋白表达。结果表明,AM2在微摩尔水平上显著抑制细胞增殖和迁移,远高于母体二甲双胍。AM2减少脂肪生成并下调Clusterin、SREBP1和FASN的表达。这些结果表明,AM2通过抑制与Clusterin/SREBP1/FASN信号通路相关的细胞脂肪生成来抑制膀胱癌细胞T24的生长。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e792/11058549/a738f879e16e/kjpp-28-3-219-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e792/11058549/95c87c1597fc/kjpp-28-3-219-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e792/11058549/410b61eceeb3/kjpp-28-3-219-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e792/11058549/e66967e13e98/kjpp-28-3-219-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e792/11058549/a738f879e16e/kjpp-28-3-219-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e792/11058549/95c87c1597fc/kjpp-28-3-219-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e792/11058549/410b61eceeb3/kjpp-28-3-219-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e792/11058549/e66967e13e98/kjpp-28-3-219-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e792/11058549/a738f879e16e/kjpp-28-3-219-f4.jpg

相似文献

1
Novel artesunate-metformin conjugate inhibits bladder cancer cell growth associated with Clusterin/SREBP1/FASN signaling pathway.新型青蒿琥酯-二甲双胍偶联物通过簇集素/固醇调节元件结合蛋白1/脂肪酸合酶信号通路抑制膀胱癌细胞生长。
Korean J Physiol Pharmacol. 2024 May 1;28(3):219-227. doi: 10.4196/kjpp.2024.28.3.219.
2
Metformin exerts an antitumor effect by inhibiting bladder cancer cell migration and growth, and promoting apoptosis through the PI3K/AKT/mTOR pathway.二甲双胍通过抑制膀胱癌细胞迁移和生长,并通过 PI3K/AKT/mTOR 通路促进细胞凋亡来发挥抗肿瘤作用。
BMC Urol. 2022 May 24;22(1):79. doi: 10.1186/s12894-022-01027-2.
3
Metformin targets Clusterin to control lipogenesis and inhibit the growth of bladder cancer cells through SREBP-1c/FASN axis.二甲双胍靶向聚集素,通过固醇调节元件结合蛋白-1c/脂肪酸合酶轴控制脂肪生成并抑制膀胱癌细胞生长。
Signal Transduct Target Ther. 2021 Mar 1;6(1):98. doi: 10.1038/s41392-021-00493-8.
4
Metformin targets a YAP1-TEAD4 complex via AMPKα to regulate CCNE1/2 in bladder cancer cells.二甲双胍通过 AMPKα 靶向 YAP1-TEAD4 复合物来调节膀胱癌细胞中的 CCNE1/2。
J Exp Clin Cancer Res. 2019 Aug 27;38(1):376. doi: 10.1186/s13046-019-1346-1.
5
Metformin can block precancerous progression to invasive tumors of bladder through inhibiting STAT3-mediated signaling pathways.二甲双胍可通过抑制STAT3介导的信号通路来阻断膀胱癌前病变向浸润性肿瘤的进展。
J Exp Clin Cancer Res. 2015 Aug 7;34(1):77. doi: 10.1186/s13046-015-0183-0.
6
Activation of sterol regulatory element-binding protein 1 (SREBP1)-mediated lipogenesis by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) promotes cell proliferation and progression of nasopharyngeal carcinoma. Epstein-Barr 病毒编码的潜伏膜蛋白 1(LMP1)激活固醇调节元件结合蛋白 1(SREBP1)介导的脂肪生成促进鼻咽癌细胞增殖和进展。
J Pathol. 2018 Oct;246(2):180-190. doi: 10.1002/path.5130. Epub 2018 Aug 22.
7
and targeting of bladder carcinoma with metformin in combination with cisplatin.以及二甲双胍联合顺铂对膀胱癌的靶向作用。
Oncol Lett. 2015 Aug;10(2):975-981. doi: 10.3892/ol.2015.3267. Epub 2015 May 26.
8
Antitumor mechanism of MAP30 in bladder cancer T24 cells, and its potential toxic effects in mice.MAP30在膀胱癌T24细胞中的抗肿瘤机制及其对小鼠的潜在毒性作用。
Cell Mol Biol (Noisy-le-grand). 2020 Apr 20;66(1):42-48.
9
Novel dihydroartemisinin derivative Mito-DHA induces apoptosis associated with mitochondrial pathway in bladder cancer cells.新型二氢青蒿素衍生物 Mito-DHA 通过线粒体途径诱导膀胱癌细胞凋亡。
BMC Pharmacol Toxicol. 2022 Jan 20;23(1):10. doi: 10.1186/s40360-021-00542-6.
10
[miR-503-5p inhibits the proliferation of T24 and EJ bladder cancer cells by interfering with the Rb/E2F signaling pathway].[微小RNA-503-5p通过干扰Rb/E2F信号通路抑制T24和EJ膀胱癌细胞的增殖]
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2017 Oct;33(10):1360-1364.

引用本文的文献

1
Causal relationship between the plasma lipidome and urological cancers: A two-sample Mendelian randomization study.血浆脂质组与泌尿系统癌症之间的因果关系:一项两样本孟德尔随机化研究。
Medicine (Baltimore). 2025 Jun 6;104(23):e42577. doi: 10.1097/MD.0000000000042577.
2
Anti-tumor mechanism of artesunate.青蒿琥酯的抗肿瘤机制。
Front Pharmacol. 2024 Oct 25;15:1483049. doi: 10.3389/fphar.2024.1483049. eCollection 2024.
3
MiR-206 Suppresses Triacylglycerol Accumulation via Fatty Acid Elongase 6 in Dairy Cow Mammary Epithelial Cells.

本文引用的文献

1
Lower dose of metformin combined with artesunate induced autophagy-dependent apoptosis of glioblastoma by activating ROS-AMPK-mTOR axis.小剂量二甲双胍联合青蒿琥酯通过激活 ROS-AMPK-mTOR 轴诱导胶质母细胞瘤自噬依赖性细胞凋亡。
Exp Cell Res. 2023 Sep 1;430(1):113691. doi: 10.1016/j.yexcr.2023.113691. Epub 2023 Jul 1.
2
Anti-Cancer Effects of Artesunate in Human 3D Tumor Models of Different Complexity.青蒿琥酯在不同复杂性的人源 3D 肿瘤模型中的抗癌作用。
Int J Mol Sci. 2023 Apr 25;24(9):7844. doi: 10.3390/ijms24097844.
3
Artesunate Combined With Metformin Ameliorate on Diabetes-Induced Xerostomia by Mitigating Superior Salivatory Nucleus and Salivary Glands Injury in Type 2 Diabetic Rats via the PI3K/AKT Pathway.
miR-206通过脂肪酸延长酶6抑制奶牛乳腺上皮细胞中三酰甘油的积累。
Animals (Basel). 2024 Sep 6;14(17):2590. doi: 10.3390/ani14172590.
青蒿琥酯联合二甲双胍通过PI3K/AKT途径减轻2型糖尿病大鼠上涎核和唾液腺损伤,改善糖尿病性口干症
Front Pharmacol. 2021 Dec 20;12:774674. doi: 10.3389/fphar.2021.774674. eCollection 2021.
4
Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 study.帕博利珠单抗单药治疗卡介苗(BCG)无应答的高风险非肌肉浸润性膀胱癌(KEYNOTE-057):一项开放标签、单臂、多中心、2 期研究。
Lancet Oncol. 2021 Jul;22(7):919-930. doi: 10.1016/S1470-2045(21)00147-9. Epub 2021 May 26.
5
Lipid metabolism in cancer: New perspectives and emerging mechanisms.癌症中的脂质代谢:新视角和新兴机制。
Dev Cell. 2021 May 17;56(10):1363-1393. doi: 10.1016/j.devcel.2021.04.013. Epub 2021 May 3.
6
Preclinical Evaluation of Artesunate as an Antineoplastic Agent in Ovarian Cancer Treatment.青蒿琥酯作为卵巢癌治疗抗肿瘤药物的临床前评价
Diagnostics (Basel). 2021 Feb 26;11(3):395. doi: 10.3390/diagnostics11030395.
7
Metformin targets Clusterin to control lipogenesis and inhibit the growth of bladder cancer cells through SREBP-1c/FASN axis.二甲双胍靶向聚集素,通过固醇调节元件结合蛋白-1c/脂肪酸合酶轴控制脂肪生成并抑制膀胱癌细胞生长。
Signal Transduct Target Ther. 2021 Mar 1;6(1):98. doi: 10.1038/s41392-021-00493-8.
8
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
9
Advances in bladder cancer biology and therapy.膀胱癌生物学和治疗的进展。
Nat Rev Cancer. 2021 Feb;21(2):104-121. doi: 10.1038/s41568-020-00313-1. Epub 2020 Dec 2.
10
Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma.阿维鲁单抗维持治疗晚期或转移性尿路上皮癌。
N Engl J Med. 2020 Sep 24;383(13):1218-1230. doi: 10.1056/NEJMoa2002788. Epub 2020 Sep 18.